
Work Here?
Work Here?
Work Here?
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Framingham, Massachusetts
Founded
2011
Definitive Healthcare provides healthcare commercial intelligence by offering a subscription-based database and analytics platform that helps clients in biopharma, medical devices, and provider organizations identify market opportunities and understand competitors. Users access the data, run analyses and reports, and visualize trends to inform sales, partnerships, and outreach to key healthcare stakeholders. The service distinguishes itself with a strict healthcare focus and scalable, domain-specific analytics that turn data into actionable insights. Its goal is to help healthcare organizations accelerate commercial success through practical, data-driven decision-making.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$483M
Above
Industry Average
Funded Over
1 Rounds
Health Insurance
401(k) Company Match
Flexible Work Hours
Emporia Research has enhanced its healthcare targeting capabilities through a collaboration with Definitive Healthcare, a provider of healthcare market data and analytics. The partnership enables more precise recruitment of healthcare executives, administrators and technical decision makers alongside NPI-verified physicians and clinical staff. The enhanced targeting now includes institutional roles, organisational affiliations, prescribing behaviour, clinical trial participation, financial relationships with manufacturers and credentialing verification. This allows research teams to reach specific individuals who influence purchasing and policy decisions within healthcare organisations. Emporia combines Definitive Healthcare's data with its own verification infrastructure, including LinkedIn verification and fraud detection. The company specialises in participant recruitment for research organisations, having raised $295 million across three funding rounds.
The biggest trends from HIMSS 2026 and what they mean for healthcare leaders. Mar 23rd, 2026 This year at HIMSS, one message was clear from nearly every conversation Definitive Healthcare Corp. had: the need for better, faster, and more actionable insights is more important than ever. As healthcare organizations work to modernize operations and expand access to care, it seems as if success increasingly depends on the ability to turn data into decisions - whether those decisions are made by AI or otherwise. The sentiment was reflected across the conference. Rather than asking, "What can this new technology do?", sessions and workshops instead focused on where these innovations can deliver measurable impact, with an emphasis on outcomes, efficiency, and scalability. If you couldn't make it to Las Vegas - or just need a quick way to revisit and share the most important discussions - Definitive Healthcare Corp. has got you covered. Below, Definitive Healthcare Corp. break down some of the major trends from HIMSS 2026 and what they mean for organizations keeping a keen eye on the future of digital health. CMS doubles down on technology as the key to cutting costs and expanding care. One of the most talked about moments at HIMSS 2026 came during CMS Administrator Dr. Mehmet Oz's keynote, where he outlined a roadmap for the future of U.S. healthcare that stressed treating patients in the home before they reach the hospital. Oz pointed to a persistent challenge facing the industry: year-over-year, healthcare costs continue to rise even as technology advances (it is usually touted as a deflationary force). Even so, Oz claims that investing in technology will be critical to lowering costs, alleviating administrative burden, reducing waste, and enabling patients and Medicare beneficiaries to make more informed decisions regarding their health. Telehealth, remote patient monitoring, and digital care models are already moving the industry in this direction. But a major focus of Oz's remarks - and a dominant theme across HIMSS - was the role of agentic AI. These systems, designed to act autonomously across workflows, have the potential to guide patients, support care decisions, and improve access to services outside of traditional clinical settings. Oz emphasized that CMS may play a role in bringing these capabilities to every Medicare beneficiary in the coming years. This vision is particularly relevant for rural healthcare, where access challenges, workforce shortages, and financial pressures continue to strain providers. At HIMSS, rural health was top of mind for many attendees. Roughly 25% of conversations at the Definitive Healthcare booth touched on this issue in some capacity. That urgency is reinforced by the launch of CMS' Rural Health Transformation (RHT) Program, a $50 billion initiative running from 2026 to 2030 aimed at stabilizing and modernizing rural care delivery. Specifically, the program's goal is to promote rural health innovation and infrastructure development while cultivating strategic partnerships and attracting a highly skilled workforce. That money, however, doesn't address the issue that many physicians and healthcare practitioners may not want to live outside of urban areas. Oz says this is where AI tools and telehealth can help. Using these technologies can extend the reach of providers into rural communities and move more care into patients' homes. Still, this marks a period of significant transformation for healthcare providers across the nation. State agencies and commercial organizations will need to identify underserved populations, track outcomes, and allocate resources effectively (among many other tasks) to make the most of the funds flowing in. The answer to these challenges, increasingly, comes down to data and clear insight into the market. Solutions like Definitive Healthcare's HospitalView and ClinicView can help organizations identify and evaluate rural providers, understand patient populations, and uncover opportunities to expand access and improve care outcomes. Tech giants are expanding their footprint in the healthcare market with agentic AI leading the way. As has been the case at nearly every major health conference in recent memory, the myriad use cases and challenges orbiting AI continue to dominate the conversation. It was no different at HIMSS, but this time the conversation leaned heavily into interrogating the tangible, practical value AI can provide. This goes beyond content generation and simple chatbot capabilities. Some of the world's largest technology companies have announced new autonomous AI agents and solutions that aim to further revolutionize healthcare. Epic, the nation's largest EHR vendor, introduced Agent Factory, a no-code platform that allows healthcare organizations to build and deploy their own AI agents within existing systems. The company also showcased a set of purpose-built AI personas designed to assist with clinical documentation, revenue cycle management, patient engagement, and more. Epic is uniquely positioned to operationalize AI at this scale, thanks to a vast install base and deep pre-existing integration into clinical workflows. At the same time, giants like Microsoft, Google Cloud, Oracle, NVIDIA, and Amazon all announced new AI tools tailored to specific healthcare use cases. The range of applications varied broadly, from optimizing supply chains and mining large datasets to enhancing clinical decision support, enabling ambient clinical documentation, improving medication adherence, and more. Together, these developments signal a rapid influx of autonomous tools entering the market, giving organizations more options than ever to embed AI across the enterprise. The momentum behind this shift is significant. According to Gartner, 15% of day-to-day work decisions are expected to be made autonomously by agentic AI by 2028, up from virtually none in 2024. Additionally, one-third of enterprise software applications will include agentic AI capabilities, compared to less than 1% today. Companies are marketing interoperability as a competitive advantage. As healthcare organizations invest more heavily in AI, it's becoming clear that interoperability is a critical enabler of success. Afterall, AI systems are only as effective as the data they're trained on, and the systems they can access. Without connected, high-quality data flowing across the ecosystem, even the most advanced tools will struggle to deliver meaningful value. This is causing many companies to take a hard look at their data, its quality, where it's stored, and how easily agents can pull information. The organizations that can unify data across clinical, operational, and financial systems are the ones more likely to remain competitive and grow in 2026 and beyond, and Definitive Healthcare Corp. saw plenty of companies positioning the interoperability of their solution as a competitive advantage. The federal government is also prioritizing data liquidity. Dr. Thomas Keane, the National Coordinator for Health Information Technology, said during a presentation at HIMSS that ease of health data exchange is a top priority and that some developers and providers may be penalized for blocking information. The reason? Clarity. Treating patients without a full picture of their health background can lead to care gaps, medical errors, readmissions, and more. For companies, an interoperable system offers greater clarity into the market, helping your customers see a connected healthcare ecosystem that brings together providers, pharmacies, labs, and other digital health platforms. What comes next for digital health. HIMSS highlighted that most companies and providers are all-in on AI. However, success will hinge on how companies will use these innovative technologies to create meaningful impact. But execution requires more than technology alone. It requires clear, connected, and reliable data - the foundation for better decisions, more efficient operations, and measurable outcomes. That's where Definitive Healthcare can help. With industry-leading datasets and solutions spanning providers, claims, and care delivery, Definitive Healthcare gives organizations the insight they need to identify opportunities, understand complex markets, and make smarter, faster decisions. Whether you're looking to expand into new markets, support rural providers, or maximize the impact of your AI and digital health investments, having the right data in place is critical. Book a demo with Definitive Healthcare to see how its data and analytics can help you drive meaningful results today. Ethan Popowitz. Ethan Popowitz is a Senior Content Writer at Definitive Healthcare. He writes data-driven articles about telehealth, AI, the healthcare staffing shortage, and everything in...
Definitive Healthcare reported Q4 revenue of $61.5 million, down year-over-year, with adjusted EBITDA of $18.1 million and trailing 12-month unlevered free cash flow of approximately $55 million. Full-year 2025 revenue reached $241.5 million, down 4% annually. Subscription revenue declined in Q4, though professional services grew due to analytics engagements and digital activations. The company highlighted progress in data differentiation, faster integrations and early generative AI product rollouts to support retention. For 2026, Definitive Healthcare guided revenue of $220-$226 million, representing a 6-9% decline, with adjusted EBITDA of $53-$58 million and margins of 24-26%. Management expects modest second-half improvement and a slight increase in net dollar retention versus 2025.
Definitive Healthcare to present at the 28th Annual Needham Growth Conference. FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) - Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference. The Definitive Healthcare presentation is scheduled for Wednesday, January 14, 2026, at 9:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the Definitive Healthcare investor relations website at https://ir.definitivehc.com/. A replay of the webcast will also be available for a limited time. About Definitive Healthcare Definitive Healthcare is a data and analytics company focused on the business side of healthcare. The healthcare market is complex - our data makes it clearer. We cut through the noise to deliver the insights that healthcare organizations and companies need to make smarter, faster, more strategic decisions. Because when our customers succeed, healthcare gets better for everyone. Learn more at definitivehc.com. Investor Contact: Brian Denyeau ICR for Definitive Healthcare [email protected] 646-277-1251
Forum ventures bets big on category-defining vertical AI solution for healthcare growth, Salubrum. Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare to provide best-in-class precision patient activation, reimagining how healthcare brands go to market. Origins of Salubrum Founded by first-generation Canadian entrepreneur Osama Usmani, Salubrum was initially focused on medical tourism. However, Usmani quickly recognized that the issue in healthcare wasn't a lack of providers, but poor commercialization. Essentially, providers were invisible to their patients, not inaccessible. Leveraging his experience as a management consultant at Deloitte, Usmani, along with his team of experts, got to work on building a new way to connect patients and providers. The team behind Salubrum found that healthcare providers struggle to acquire patients online due to a lack of access to data, workflows, and tools needed to capitalize on growing demand. By building its AI engine, Salubrum sifts through low-quality search results, generic ads, and unsafe options, showcasing healthcare providers to real, high-intent patients, building trust and access. "After speaking to patients and providers in 2024, Salubrum evolved into a vertical AI company focused on creating real demand activation for healthcare brands," Usmani stated. "The goal: unlock access for patients and growth for providers; starting with 1:1 targeting, expanding into a full commercialization platform." True Vertical Specialization
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Framingham, Massachusetts
Founded
2011
Find jobs on Simplify and start your career today